Important Happenings in HIV/Health Policy

Important Happenings in HIV/Health Policy

Week ending: April 5, 2019
By: Sable K. Nelson

Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy for HIV Pre-Exposure Prophylaxis

Sable K. NelsonOn April 5, 2019– Gilead Sciences, Inc. announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for Descovy® (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection among individuals who are HIV-negative and at risk for HIV. A Priority Review voucher was submitted with the filing, leading to an anticipated review time of six months. For more information, READ → http://www.natap.org/

Podcast: KHN’s ‘What The Health’ The GOP’s Health Reform Whiplash

Rebecca Adams of CQ Roll Call, Anna Edney of Bloomberg News and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss the latest “will they or won’t they?” when it comes to Republicans and comprehensive health reform. Also, a wrap-up of the latest abortion fights in the states and on Capitol Hill. And, another court setback for the Trump administration’s efforts to undermine the Affordable Care Act. Plus, Rovner interviews KHN’s Paula Andalo about the latest “Bill of the Month” feature. For more information, CLICK HERE TO LISTEN.

 

Podcast: What’s Up With Trump’s Sudden Turnaround On Health Care?

President Donald Trump promises that Republicans will be the “party of health care” and seeks to have a court overturn the Affordable Care Act. But that leaves some Republican lawmakers nervous about bringing the contentious issue up before the 2020 elections. KHN’s Julie Rovner talks to “Detroit Today” host Stephen Henderson about the implications of the president’s moves. For more information, CLICK HERE TO LISTEN

 

Podcast: KHN’s ‘What The Health’ Health Care’s Back (In Court)

It’s been a wild week for health policy, mostly because of developments surrounding two different legal cases. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to sort it out with a discussion of a setback for Medicaid work requirements and the Trump administration’s decision to back a lawsuit claiming the entire Affordable Care Act is unconstitutional. Also, Rovner interviews filmmaker Mike Eisenberg about his movie “To Err Is Human: A Patient Safety Documentary.” For more information → CLICK TO READ

Virtual Listening Sessions: Opportunities to Inform Development of an STD Federal Action Plan – April 17 and May 9, 2019

The U.S. Department of Health & Human Services Office of HIV/AIDS and Infectious Disease Policy (OHAIDP) will host two virtual listening sessions to gather public input to inform the development of a Sexually Transmitted Diseases (STD) Federal Action Plan.

Register for Listening Sessions

Your thoughts and recommendations are important, so HHS is offering listening sessions to provide the opportunity for people from across the United States to participate.  Please consider joining one of these listening sessions.  To do so, please register through the links below:
• Wednesday, April 17, 2019:  Virtual Listening Session from 3:30—5:00 pm (ET).  Click here to register.

Also Share Your Comments in Writing

In addition, HHS will soon publish a Request for Information (RFI) in the Federal Register to solicit written comments and recommendations for the STD Federal Action Plan that is being developed.  As soon as the RFI is published, HHS will post a link to it as well as information about the deadline for input.

 

What You Can Do

TAKE ACTION: It is very important that our elected officials hear from us to protect federal funding for HIV prevention and care. Speak truth to power by sharing your personal stories with your elected officials. It is vitally important to meet with your federal elected officials when they are at home. If we don’t support and advocate for HIV funding and programs, who will?  Our movement cannot afford to stand on the sidelines. Your U.S. Senators and U.S. Representatives need to hear from you.

 

What NMAC is Doing About It

  • NMAC remains vigilant in its advocacy to protect FY20 government funding and the existence of the social safety net.
  • NMAC is working in coalition to defend the right of people living with HIV to serve in the US military.